GBP75000 - GBP90000 per year: Immunocore: Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose...
Vous n'êtes pas connecté
GBP34000 - GBP40000 per year: Immunocore: Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new Abingdon, England, Oxfordshire / Oxfordshire, England, Didcot / Oxfordshire, England, Oxford
GBP75000 - GBP90000 per year: Immunocore: Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose...
GAITHERSBURG, Md., July 02, 2024. artesian Therapeutics, Inc. (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell...
Cartesian Therapeutics, Inc, a clinical─stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, announced that the first...
STAMFORD, Conn., July 01, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused...
To define: Oxford BioMedica (UK) Limited: Job description: We want you to feel inspired every day. We’re future-focused and our business is...
Charles River (CRL) signs a lentiviral vector contract development and manufacturing organization agreement with Gates Institute to help develop...
A taxpayer-funded project in the UK is set to research connections between milk and colonialism. Academics at an Oxford museum will research the...
Competitive: Worldwide Clinical Trials - USA: Who we are Worldwide, a leading global contract research organization (CRO), works in partnership...
Not specified: headcount AG: Search for Senior Scientist Protein Selection and Screening Our client is an innovative biotech startup and is...
Competitive: ICON Strategic Solutions: Experienced England, UK-based CRA/clinical research associate required to augment existing non-Oncology CRA...